Detalhe da pesquisa
1.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Lancet
; 403(10421): 31-43, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048793
2.
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Lancet Oncol
; 25(2): 255-264, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142702
3.
Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta-analysis.
Cancer
; 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306301
4.
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer.
Br J Cancer
; 130(3): 425-433, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097739
5.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecol Oncol
; 185: 128-137, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412736
6.
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.
Cancer
; 129(7): 1085-1095, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642837
7.
Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol.
BMC Cancer
; 23(1): 1178, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041077
8.
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Gynecol Oncol
; 169: 78-84, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521352
9.
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Gynecol Oncol
; 170: 186-194, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706645
10.
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy.
J Natl Compr Canc Netw
; 21(5): 473-479.e4, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156482
11.
Posttraumatic Stress Symptoms in Patients With Cancer During the COVID-19 Pandemic: A One-Year Longitudinal Study.
J Natl Compr Canc Netw
; 21(3): 265-272.e7, 2023 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812938
12.
Development of the Cold Agglutinin Disease Symptoms and Impact Questionnaire (CAD-SIQ).
Eur J Haematol
; 111(2): 211-219, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37128840
13.
Sutimlimab provides clinically meaningful improvements in patient-reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo-controlled, Phase 3 CADENZA study.
Eur J Haematol
; 110(3): 280-288, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403132
14.
Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse.
Int J Gynecol Cancer
; 33(4): 577-584, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631150
15.
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
Int J Gynecol Cancer
; 33(5): 649-666, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37127326
16.
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era.
Br J Cancer
; 127(1): 79-83, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361918
17.
Self-referential processes and resting-state connectivity in breast cancer patients before and 1 year after chemotherapy.
Eur J Neurosci
; 55(2): 624-636, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34978117
18.
Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis.
Breast Cancer Res Treat
; 191(2): 459-469, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34817750
19.
Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial.
BMC Cancer
; 22(1): 1308, 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513991
20.
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.
BMC Cancer
; 22(1): 1213, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434554